01513.HK
Livzon Pharmaceutical Group, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 23.18
+4.32%Leverage
- Debt / equity
- 0.32x
- Net debt / equity
- -0.23x
- Debt / assets
- 0.18x
- Debt / EBITDA
- 1.58x
- Net debt / EBITDA
- -1.15x
Liquidity & coverage
- Current ratio
- 1.48x
- Quick ratio
- 1.27x
- Cash ratio
- 0.87x
- Interest coverage
- 46.99x
- EBITDA / interest
- 59.82x
- Working capital
- HKD 4.8B
Cash & dividend
- FCF / debt
- 0.66x
- Cash flow / debt
- 0.76x
- Dividend per share
- HKD 2.83
- Dividend yield
- 12.2%
- Dividend growth 1y
- +135.9%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026